Jupiter Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Hold
50,050
0.51% 41
2025
Q4
$1.37M Buy
50,050
+17,450
+54% +$440K 0.61% 40
2025
Q3
$831K Hold
32,600
0.39% 52
2025
Q2
$820K Hold
32,600
0.41% 52
2025
Q1
$750K Sell
32,600
-39,150
-55% -$1.02M 0.45% 47
2024
Q4
$1.9M Buy
71,750
+4,000
+6% +$108K 0.95% 27
2024
Q3
$1.96M Sell
67,750
-3,390
-5% -$98.9K 1% 28
2024
Q2
$2.17M Buy
71,140
+3,390
+5% +$93.3K 1.15% 28
2024
Q1
$1.92M Buy
67,750
+10,150
+18% +$282K 1.01% 30
2023
Q4
$1.66M Buy
57,600
+9,000
+19% +$272K 0.98% 28
2023
Q3
$1.43M Hold
48,600
0.93% 29
2023
Q2
$1.78M Sell
48,600
-2,600
-5% -$101K 1.53% 18
2023
Q1
$2.09M Buy
51,200
+2,600
+5% +$112K 1.92% 19
2022
Q4
$2.49M Hold
48,600
2.41% 15
2022
Q3
$2.13M Sell
48,600
-41,685
-46% -$2.03M 2.13% 18
2022
Q2
$4.73M Hold
90,285
4.31% 7
2022
Q1
$4.67M Buy
90,285
+19,685
+28% +$1.02M 2.92% 10
2021
Q4
$4.17M Sell
70,600
-11,030
-14% -$546K 2.16% 16
2021
Q3
$4M Buy
81,630
+20,000
+32% +$886K 1.89% 18
2021
Q2
$2.78M Sell
61,630
-21,500
-26% -$836K 1.33% 24
2021
Q1
$3.21M Buy
83,130
+17,500
+27% +$621K 1.62% 23
2020
Q4
$2.42M Sell
65,630
-39,285
-37% -$1.44M 1.48% 21
2020
Q3
$3.65M Sell
104,915
-45,949
-30% -$1.61M 2.58% 15
2020
Q2
$5.22M Buy
150,864
+137,057
+993% +$4.66M 2.61% 16
2020
Q1
$493K Sell
13,807
-1,054
-7% -$35.9K 0.29% 47
2019
Q4
$565K Hold
14,861
0.27% 51
2019
Q3
$507K Hold
14,861
0.27% 49
2019
Q2
$603K Hold
14,861
0.3% 45
2019
Q1
$555K Buy
+14,861
New +$595K 0.27% 46

Other funds holding PFE

Jupiter Wealth Management's PFE Position: Q1 2026 in Review

Jupiter Wealth Management held its Pfizer (PFE) position steady in Q1 2026 at 50,050 shares worth $1.3M. The position accounts for 0.51% of the portfolio, ranked #41.

Jupiter Wealth Management first reported a position in PFE in Q1 2019 and has held it in 29 quarters since. The position peaked at $5.22M in Q2 2020. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Jupiter Wealth Management held 50,050 shares of Pfizer worth $1.3M as of Q1 2026.
  • Jupiter Wealth Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.51% of Jupiter Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Jupiter Wealth Management first reported a position in Pfizer in Q1 2019 and has held it in 29 quarters since.
  • Jupiter Wealth Management's Pfizer position peaked at $5.22M in Q2 2020.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Jupiter Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.